Thyrocare Promoter Docon Sells 9.90% Stake

Thyrocare Technologies Limited has announced that Docon Technologies Private Limited, a promoter, has sold 1,57,69,696 equity shares, representing approximately 9.90% of the company's paid-up equity share capital. The sale occurred through market trades on August 13, 2026. Following this transaction, Docon remains a promoter, and its shareholding in Thyrocare has reduced from 60.92% to 51.02%. The settlement of the transaction will be conducted in compliance with applicable laws and regulations. This disclosure impacts the promoter shareholding structure of the company.